Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positi... by Lee, S, Abboud, H, Irani, SR, Nakajima, H, Piquet, AL, Pittock, SJ, Yeh, EA, Wang, J, Rajan, S, Overell, J, Smith, J, St Lambert, J, El-Khairi, M, Gafarova, M, Gelfand, JM

Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis by Arnett, S, Chew, SH, Leitner, U, Hor, JY, Paul, F, Yeaman, MR, Levy, M, Weinshenker, BG, Banwell, BL, Fujihara, K, Abboud, H, Dujmovic Basuroski, I, Arrambide, G, Neubrand, VE, Quan, C, Melamed, E, Palace, J, Sun, J, Asgari, N, Broadley, SA

Specificities of ischemic stroke risk factors in Arab-speaking countries by Abboud, H, Sissani, L, Labreuche, J, Arauz, A, Bousser, M-G, Bryer, A, Chamorro, A, Fisher, M, Ford, I, Fox, KM, Hennerici, MG, Lavados, PM, Massaro, A, Mattle, HP, Collazos, M, Rothwell, PM, Steg, PG, Vicaut, E, Yamouth, B, Amarenco, P

Five-year risk of stroke after TIA or minor ischemic stroke by Amarenco, P, Lavallée, PC, Tavares, L, Labreuche, J, Albers, GW, Abboud, H, Anticoli, S, Audebert, H, Bornstein, NM, Caplan, LR, Correia, M, Donnan, GA, Ferro, JM, Gongora-Rivera, F, Heide, W, Hennerici, MG, Kelly, PJ, Král, M, Lin, H-F, Molina, C, Park, JM, Purroy, F, Rothwell, PM, Segura, T, Školoudík, D, Steg, PG, Touboul, P-J, Uchiyama, S, Vicaut, É, Wang, Y, Wong, LKS